ArticleSexually transmitted diseases2025
Prevalence of Chlamydia trachomatis Genital Infection Among Sexually Experienced Females Aged 14 to 24 Years by Race/Ethnicity, United States: 2011 to March 2020.
Article in Sexually transmitted diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Validation of diagnostic codes for identifying chlamydial infections from TriNetX electronic health record data in the United States.Sexually transmitted diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundSince 2013, national trends in behavioral factors that increase sexually transmitted infection risk among adolescent and young adult (A/YA) females have been mixed (e.g., fewer sex partners, lower condom use). We used data from a national sample of A/YA females to examine racial disparities in Chlamydia trachomatis (CT) prevalence considering these trends.
methodsUsing 2011-March 2020 National Health and Nutrition Examination Survey data, we estimated the prevalence, and unadjusted and adjusted prevalence ratios of a positive CT urine test result among sexually experienced non-Hispanic Black (Black), Hispanic, non-Hispanic Other race (NHO), and non-Hispanic White (White) A/YA females. Percentages were categorized by race/ethnicity, and each was compared with the average of the other race/ethnic groups (e.g., Black vs. Hispanic, NHO, and White). Covariates included age group, health insurance coverage, number of sex partners, and condom use (both past year).
resultsOverall, the prevalence of CT infection among A/YA females was 5.8% (95% confidence interval [CI], 4.5%-7.3%). The prevalence of CT was higher among Black females (vs. Hispanic, NHO, and White; 11.7%; 95% CI, 8.7%-15.2%) and lower among White females (vs. Black, Hispanic, and NHO; 3.2%; 95% CI, 1.7%-5.5%). Compared with the average CT prevalence for Hispanic, NHO, and White females, Black females had a higher adjusted CT prevalence (adjusted prevalence ratio, 2.48; 95% CI, 1.63-3.75).
conclusionsNationally, CT prevalence was 2.5 times as high among Black A/YA females than the average prevalence for Hispanic, NHO, and White females. Inclusion of behavioral sexually transmitted infection risk factors did not attenuate this association. Research incorporating sexual network-level factors associated with CT transmission may provide additional insights.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.